ZFAS1 and central nervous system cancer: In cancers, ZFAS1 is thought to be overexpressed in most human cancers, including nonsmall cell lung cancer (Ge et al., 2020), colorectal cancer (Wu et al., 2020), glioma (Li et al., 2020), hepatocellular carcinoma (Liang et al., 2019) and head and neck cancer (Kolenda et al., 2019).